Table 1.
Characteristics of cancer survivors in the Health Information National Trends Survey (HINTS 4 Cycle 2) by treatment summary receipt.
| Total Samplea,b | Did not receive treatment summary | Received treatment summary | X2 p-value (unadjusted) | |
|---|---|---|---|---|
| N = 359 | 235 (65.5) | 124 (34.5) | ||
| Demographic and Socioeconomic Factors | ||||
| Gender | .847 | |||
| Male | 153 (42.6) | 99 (42.5) | 54 (43.5) | |
| Female | 204 (56.8) | 134 (57.5) | 70 (56.5) | |
| Age | .258 | |||
| 18–49 | 51 (14.2) | 29 (12.5) | 22 (17.7) | |
| 50–64 | 105 (29.2) | 64 (27.6) | 41 (33.1) | |
| 65–74 | 104 (29.0) | 72 (31.0) | 32 (25.8) | |
| 75+ | 96 (26.7) | 67 (28.9) | 29 (23.4) | |
| Education | .496 | |||
| Less than High School | 24 (6.7) | 19 (8.2) | 5 (4.0) | |
| High School | 85 (23.7) | 53 (22.8) | 32 (25.8) | |
| Some College | 122 (34.0) | 79 (34.1) | 43 (34.7) | |
| College Graduate | 125 (34.8) | 81 (34.9) | 44 (35.5) | |
| Annual Income | .926 | |||
| < $20K | 57 (15.9) | 39 (16.6) | 18 (14.5) | |
| $20K to < $50K | 101 (28.1) | 64 (27.2) | 37 (29.8) | |
| $50K to < $75K | 55 (15.3) | 37 (15.7) | 18 (14.5) | |
| $75K or more | 88 (24.5) | 59 (25.1) | 29 (23.4) | |
| Refused/don’t know/missing | 58 (16.2) | 36 (15.3) | 22 (17.7) | |
| Race/ethnicity | .060 | |||
| White (Non-Hispanic) | 266 (74.1) | 184 (78.3) | 82 (66.1) | |
| Hispanic/Latino(a) | 26 (7.2) | 15 (6.4) | 11 (8.9) | |
| NH African American | 24 (6.7) | 11 (4.7) | 13 (10.5) | |
| NH Other/Not reported | 43 (12.0) | 25 (10.6) | 18 (14.5) | |
| Cancer-Related Factors | ||||
| Time Since Treatment | .456 | |||
| Less than 1 yr | 54 (15.0) | 33 (14.0) | 21 (16.9) | |
| 1 to less than 5yrs | 102 (28.4) | 63 (26.8) | 39 (31.5) | |
| 5 to less than 10 yrs | 83 (23.1) | 54 (23.0) | 29 (23.4) | |
| 10 or more yrs | 120 (33.4) | 85 (36.2) | 35 (28.2) | |
| Treatment Burden | .007 | |||
| Received one type of cancer treatment | 219 (61.0) | 157 (67.4) | 62 (50.4) | |
| Received two types of cancer treatment | 100 (27.9) | 55 (23.6) | 45 (36.6) | |
| Received three or more types of cancer treatment | 37 (10.3) | 21 (9.0) | 16 (13.0) | |
| Cancer Type | .460 | |||
| Breast | 53 (14.8) | 31 (13.4) | 22 (17.7) | |
| Colorectal | 8 (2.2) | 6 (2.6) | 2 (1.6) | |
| Prostate | 41 (11.4) | 26 (11.3) | 15 (12.1) | |
| Melanoma | 19 (5.3) | 11 (4.8) | 8 (6.5) | |
| Other Female Cancers | 38 (10.6) | 21 (9.1) | 17 (13.7) | |
| Other Cancers | 129 (35.9) | 87 (37.7) | 42 (33.9) | |
| Multiple cancers | 67 (18.7) | 49 (21.2) | 18 (14.5) | |
| Current Clinical Factors | ||||
| Overall Health Status | .129 | |||
| Poor/fair | 84 (23.4) | 49 (21.5) | 35 (28.9) | |
| Good | 117 (32.6) | 74 (32.5) | 43 (35.5) | |
| Very good/excellent | 148 (41.2) | 105 (46.1) | 43 (35.5) | |
| Number of Comorbid Conditions | .764 | |||
| 0 | 65 (18.1) | 45 (19.7) | 20 (16.5) | |
| 1–2 | 174 (48.5) | 112 (49.1) | 62 (51.2) | |
| 3+ | 110 (30.6) | 71 (31.1) | 39 (32.2) | |
| Regular Provider | .594 | |||
| No | 47 (13.1) | 29 (12.6) | 18 (14.6) | |
| Yes | 306 (85.2) | 201 (87.4) | 105 (85.4) | |
a
Total sample limited to those who reported a personal history of cancer who had undergone and completed treatment.
b
Subcategories for each factor may not sum to total N due to missing data.